繁體版 / 簡體版
 
NEWS ROOM
/ NEWS ROOM
2018-06-07
Fountain Biopharma Inc. Granted Singapore Patent for Method of Producing Mono-glycosylated Antibody

Fountain Biopharma Inc. announces a method of producing mono-glycosylated antibody was received patent from Singapore Intellectual Property Office (IPOS).

Title of the patent is “METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION”, patent no.11201607759R.

The method optimizes the glycosylation of the antibody through cell engineering technology will effectively reduce the cost of production of glycan-modified antibody which will increase the profit.

Fountain Biopharma Inc. Granted USA Patent for Method of Producing Mono-glycosylated Antibody in 2017.


玩ag电子游戏被黑钱